# Hemogenyx Pharmaceuticals Plc (HOPHF)

> Healthcare · GB · Reports in GBP

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HOPHF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | £ 0 | £ -9.76M | £ -3.45M | £ 2.00M | £ 1.20M |
| 2024 | £ 0 | £ -5.84M | £ -2.34M | £ 2.62M | £ 897.5K |
| 2023 | £ 0 | £ -7.2K | £ -6.69M | £ 2.95M | £ 2.82M |
| 2022 | £ 0 | £ -4.46M | £ -3.72M | £ 3.42M | £ 3.28M |
| 2021 | £ 0 | £ -6.24M | £ -4.20M | £ 10.2K | £ 8.19M |
| 2020 | £ 0 | £ -2.67M | £ -2.81M | £ 1.63M | £ 890.8K |
| 2019 | £ 0 | £ -1.88M | £ -1.55M | £ 1.26M | £ -346.5K |
| 2018 | £ 0 | £ -1.95M | £ -1.81M | £ 1.17M | £ 959.2K |
| 2017 | £ 0 | £ -3.34M | £ -691.0K | £ 0 | £ 2.13M |
| 2016 | £ 0 | £ -714.2K | £ -641.5K | £ 301.8K | £ 903.7K |
| 2015 | £ 9.6K | £ -257.3K | £ 107.1K | £ 241.6K | £ 77.8K |
| 2014 | £ 0 | £ -4.4K | £ -4.4K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.68 |
| Liabilities / Eq | 2.54 |
| Current Ratio | 1.38 |

## Other views

- [Metrics](https://sponda.capital/en/HOPHF.md)
- [Charts](https://sponda.capital/en/HOPHF/charts.md)
- [Compare](https://sponda.capital/en/HOPHF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.